The largest holder of Pfizer stock is BlackRock Advisors LLC, with 384.1 million shares (6.74% of the company), worth about $10.93 billion as of September 25, 2026. The 10 largest holders together own 31.2%.
In Q2 2026, 2,975 institutional holdings reports listed 4.05 billion shares worth $102.00 billion, up 7.7% in shares from Q1 2026.
Insiders reported 33 transactions in the last two years: 3 sales worth $199,486 and 5 purchases. The newest one on file is from August 12, 2026 (Bourla Albert, Chief Executive Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through August 12, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 384.1 million | 6.74% | $10.9B |
| Vanguard Capital Management LLC | 372.1 million | 6.53% | $10.6B |
| State Street Corporation | 307.1 million | 5.39% | $8.7B |
| Geode Capital Management LLC | 135.3 million | 2.37% | $3.9B |
| Ishares (DE) InvAG mit Teilgesellschaftsvermogen | 134.1 million | 2.35% | $3.8B |
| Vanguard Portfolio Management LLC | 119.2 million | 2.09% | $3.4B |
| Fisher Asset Management LLC | 109.1 million | 1.91% | $3.1B |
| Eaton Vance Management | 96.3 million | 1.69% | $2.7B |
| Norges Bank (13F) | 61.5 million | 1.08% | $1.8B |
| Vanguard Fiduciary Trust Co. | 60.6 million | 1.06% | $1.7B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,975 | 4.05 billion | $102.0B |
| Q1 2026 | 3,113 | 3.76 billion | $106.0B |
| Q4 2025 | 3,084 | 3.75 billion | $93.4B |
| Q3 2025 | 2,998 | 3.66 billion | $93.2B |
| Q2 2025 | 2,972 | 3.77 billion | $91.4B |
| Q1 2025 | 3,088 | 3.76 billion | $97.5B |
| Q4 2024 | 3,163 | 3.76 billion | $100.0B |
| Q3 2024 | 3,074 | 3.82 billion | $111.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Bourla Albert | Aug 12, 2026 | Chief Executive Officer | Purchase at price 26.34 per share. | $1.0M |
| Damico Jennifer B. | Aug 5, 2026 | Officer | Sale at price 25.40 per share. | $83,261 |
| Buckley Mortimer J. | Aug 5, 2026 | Director | Purchase at price 25.52 per share. | $960,369 |
| Blaylock Ronald E | Aug 5, 2026 | Director | Purchase at price 25.46 per share. | $998,821 |
| Damico Jennifer B. | Jun 9, 2026 | Officer | Sale at price 25.70 per share. | $51,400 |
| Damico Jennifer B. | Mar 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Sahni Payal | Feb 25, 2026 | Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $1.9M |
| Mcdermott Michael | Feb 25, 2026 | Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $1.3M |
| Damico Jennifer B. | Feb 25, 2026 | Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $593,812 |
| Bourla Albert | Feb 25, 2026 | Chief Executive Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $16.6M |
| Lankler Douglas M | Feb 25, 2026 | Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $4.2M |
| Fonseca Lidia Ph.D. | Feb 25, 2026 | Officer | Conversion of Exercise of derivative security at price 33.82 per share. | $1.9M |
Newest 12 of 33 insider transactions in the last two years.
BlackRock Advisors LLC, with 6.74% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.53%) and State Street Corporation (5.39%).
2,975 institutional holdings reports listed Pfizer shares in Q2 2026, 4.05 billion shares in all worth $102.00 billion.
In the last two years insiders reported 3 sales and 5 purchases (33 transactions in all); the newest on file is from August 12, 2026.